IN-VITRO EFFICACY OF PIPERACILLIN/SULBACTAM AGAINST MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA: A COMPARATIVE STUDY WITH PIPERACILLIN/TAZOBACTAM AND CEFOPERAZONE/SULBACTAM. Frontier in Medical and Health Research, [S. l.], v. 4, n. 3, p. 4971–4977, 2026. Disponível em: https://fmhr.net/index.php/fmhr/article/view/3904.. Acesso em: 8 nov. 2026.